University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer earlier. This tool may help guide treatment, such as signalling when to ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...

Prostate cancer remains one of the most common cancers among men, yet diagnosing it accurately has long been a challenge. The widely used PSA blood test often leads to confusion, as it can flag benign ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...

“With this test, it could be possible to turn the tide on prostate cancer. We have shown that a relatively simple, inexpensive spit test to identify men of European heritage at higher risk due to ...

A new artificial intelligence tool developed by the Hospital Clínic de Barcelona will facilitate the diagnosis of prostate cancer using magnetic resonance imaging, leading to improved treatment for ...

A new study is set to investigate how AI could significantly improve doctors’ decisions regarding prostate cancer treatment. While diagnostic methods for the disease have become safer and more precise ...